Market Place
Sourcing Support
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Did a 29 year-old show GlaxoSmithKline that it made a billion dollar mistake?
29 year-old healthcare investor, Vivek Ramaswamy, bought an old Alzheimer's drug that GlaxoSmithKli
Pharma Chess: Strategies adopted in the United States to block generics
When a generic drug comes to the U.S.
market, sales of brand drugs crash. The drop is more than 80%
Dr. Reddy’s expansion plans for API production
Unrelated to the inspection of
the USFDA at the Dr. Reddys Srikakulam facility, Dr. Reddys sought pe
